| |
Goal and Objectives
Our goal is to mobilize public support for cancer research so
that we can accelerate the nation’s progress toward the
prevention and cure of cancer. Toward that end, our objectives
are to:
- Demonstrate the benefits of cancer research;
- Illustrate the need for answers to this terrible disease;
and
- Explain the investment needed for the task ahead.
|
A. |
Congressional Update
The FY 2003 budget completes the
five-year doubling effort with $27.17 billion, a total increase of $3.79
billion over FY 2002; however the FY 2004 budget request has fallen
short of expected needs, giving the NIH only a 2% increase around $50
million. This is well below needs and recommendations. In its annual
"Federal Funding for Biomedical and Related Life Sciences Research"
recommendations, FASEB called for a 10% increase, or $2.7 billion. The
2% increase would create a lack of funds that would cripple the agency’s
ability to support individual investigator grants, the backbone of new
discoveries. With this little increase it is estimated that between
1,000 and 1,200 grants will not receive funding. The fight for a greater
increase is not over and we will certainly press this issue as much as
possible.
|
| B. |
Friends
Accomplishments During the month of February Friends
has been working to set up a forum in collaboration with the Woodrow Wilson
Center. This event, to take place in May, will honor Sherry Lansing and
Betty Ford for their commitment to curing cancer. The goal of the forum is
to create awareness about new and emerging science that will offer highly
effective treatments with little, or no toxicity. Highlighting the major
opportunities a panels of experts will speak on the promises of new medicine
and the possible barriers to progress. Topics may include chemoprevention,
molecular signatures of cancer cells, pharmacogenomics (the study of how
genetic makeup affects a person’s reaction to a particular drug),
micro-imaging techniques, and the advancements offered by the Human Genome
Project. Anticipated and existing barriers that will be addressed may
include the regulatory environment, the inability to filter new and emerging
science into the government, and the problems with Medicare and CMS
reimbursements. We are also looking at the possibility of holding a forum in
New York about the future of medicine.
|
|
|
|
Ellen Sigal |
Marlene Malek |
|
Chair |
President |
|
|
| |
|
|
| |
|
|
|
|